Ikapharmindo Putramas Tbk. vs Reksa Dana Indeks Simas ETF IDX30 — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B), while Reksa Dana Indeks Simas ETF IDX30 trades at Rp88 (market cap 11.05B). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 27.9× Reksa Dana Indeks Simas ETF IDX30's market cap. Which is the better fit depends on your goals.
| IKPM | XSBC | |
|---|---|---|
Market Cap | 308.29B | 11.05B |
Indicative Equilibrium Price | 183 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →